Progressive renal disease: Fibroblasts, extracellular matrix, and integrins

Experimental Nephrology

Volumn 7, Issue 2, 1999, Pages 167-177

  Norman, Jill T ^a,b   Fine, Leon G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Extracellular matrix; Fibrosis; Integrins; Interstitital fibroblasts

Indexed keywords

INTEGRIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; KIDNEY FIBROSIS; MYOFIBROBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0032956765     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020597     Document Type: Review

References (94)

1. Hyres RO: Integrins: Versatility, modulation and signaling in cell adhesion. Cell 1992;69: 11-25.
2. Akiyama SK: Integrins in cell adhesion and signaling. Hum Cell 1996;9:181-186.
3. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 1996;268:233-239.
4. Giancotti FG: Integrin signaling: Specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997;9:691-700.
5. Meredith JE, Winitz S, McArthur Lewis J, Hess S, Ren X-D, Renshaw MW, Schwartz MA: The regulation of growth and intracellular signaling by integrins. Endocr Rev 1996;17: 207-220.
6. Yamada KM: Integrin signaling. Matrix Biol 1997;16:137-141.
7. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 1993;120: 577-580.
8. Brooks PC, Klemke RL, Schön S, Lewis JM; Schwartz MA, Cheresh DA: Insulin-like growth factor receptor cooperates with integrin avβ5 to promote tumor cell dissemination in vivo. J Clin Invest 1997;99:1390-1398.
9. Woodard AS, Garcia-Cardena G, Leong M, Madri JA, Sessa WC, Languino LR: The synergistic activity of avβ3 integrin and PDGF receptor increases cell migration. J Cell Sci 1998; 111:469-478.
10. Lichtner RB, Howlett AR, Lerch M, Xuan JA, Brink J, Langton-Webster B, Schneider MR: Negative cooperativity between alpha3beta1 and alpha2beta1 integrins in human mammary carcinoma MDA MB231 cells. Exp Cell Res 1998;240:368-376.
11. Higgins JM, Mandlebrot DA, Shaw SK, Russell GJ, Murphy EA, Chen YT, Nelson WJ, Parker CM, Brenner MB: Direct interaction of integrin alpha E beta7 with E-cadherin. J Cell Biol 1998;141:197-210.
12. Kadmon G, Altevogt P: The cell adhesion molecule L1: Species- and cell-type-dependent multiple binding mechanisms. Differentiation 1997;61:143-150.
13. Huttenlocjer A, Lokonishok M, Kinder M, Wu S, Truong T, Knudsen KA, Horwitz AF: Integrin and cadherin synergy regulate inhibition of migration and motile activity. J Cell Biol 1998;141:515-526.
14. Ignotz RA, Massague J: Cell adhesion protein receptors are targets for transforming growth factor-β. Cell 1987;51:189-195.
15. Pickering JG, Uniyal S, Ford CM, Chau T, Laurin MA, Chow LH, Ellis CG, Fish J, Chan BM: Fibroblast growth factor-2 potentiates vascular smooth muscle cell migration to platelet-derived growth factor: Upregulation of integrin and disassembly of actin filaments. Circ Res 1997;80:627-637.
16. Xu J, Clark RAF: Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 1996;132:239-249.
17. Ashkenas J, Damsky CH, Bissell MJ, Werb Z: Integrins: Signaling and the remodeling of the extracellular matrix; in Cheresh DA, Mecham RP (eds): Integrins: Molecular and Biological Responses to the Extracellular Matrix. San Diego, Academic Press, 1994, pp 79-109.
18. Paller M: Integrins and repair after acute renal injury. Kidney Int 1997;52(suppl 61):52-55.
19. Lieberthal W, McKenny JB, Keifer CR, Snyder LM, Kroshian VM, Sjaastad MD: Beta-1-integrin-mediated adhesion between renal tubular cells after anoxic injury. J Am Soc Nephrol 1997;8:175-183.
20. Romanov V, Noiri E, Czerwinski G, Finsinger D, Kesser H, Goligorsky MS: Two novel probes reveal tubular and vascular Arg-Gly-Asp (RGD) binding sites in the ischemic rat kidney. Kidney Int 1997;52:93-102.
21. Hillis GS, Roy-Chaudhury P, Duthie LA, Stewart KN, Brown PA, Simpson JG, Mac-Leod AM: Expression of β1 integrins in IgA nephropathy. Nephrol Dial Transplant 1997; 12:1137-1142.
22. Roy-Chaudhury P, Hillis G, McDonald S, Simpson JG, Power DA: Importance of the tubulointerstitium in human glomerulonephritis. II. Distribution of integrin chains β1, α1 to 6 and αV. Kidney Int 1997;52:103-110.
23. Roy-Chaudhury P, Wu B, King G, Campbell M, MacLeod AM, Haites N, Simpson JG, Power DA: Adhesion molecule interactions in human glomerulonephritis: Importance of the tubulointerstitium. Kidney Int 1996;49:127-134.
24. Jin DK, Fish AJ, Wayner EA, Mauer M, Setty S, Tsilibary E, Kim Y: Distribution of integrin subunits in human diabetic kidneys. J Am Soc Nephrol 1996;7:2636-2645.
25. Tang WW, Feng L, Xia Y, Wilson CB: Extracellular matrix accumulation in immune mediated tubulointerstitial injury. Kidney Int 1994;45:1077-1084.
26. Eddy A: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495-2508.
27. Kaissling B, Hegyi I, Loffing J, Le Hir M: Morphology of interstitial cells in the healthy kidney. Anat Embryol 1996;193:303-318.
28. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterisation of a fibroblast marker: FSP1. J Cell Biol 1995;130:393-405.
29. Saalbach A, Aust G, Haustein UF, Herrman K, Anderegg U: The fibroblast-specific Mab AS02: A novel tool for detection and elimination of human fibroblasts. Cell Tissue Res 1997;290:593-599.
30. Bosseloir A, Heinen E, Defrance T, Bouzhazha F, Antione N, Simar LJ: Moabs MASS16 and 5B5, two fibroblast markers, recognise human follicular dendritic cells. Immunol Lett 1994; 42:49-54.
31. El Nahas M: Renal scarring: A multi-organ approach to fibrosis. Exp Nephrol 1995;3:65-148.
32. Schmitt-Graff A, Desmoulière A, Gabbiani G: Heterogeneity of myofibroblast phenotypic features: An example of fibroblastic cell plasticity. Virchows Arch 1994;425:3-24.
33. Groma V: Demonstration of collagen type VI and alpha-smooth muscle actin in renal fibrotic injury in man. Nephrol Dial Transplant 1998; 13:305-312.
34. Hägg PM, Hägg PO, Peltonen S, Autio-Harmainen H, Pihlajaniemi T: Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am J Pathol 1997;150:2075-2086.
35. Romberger DJ: Fibronectin. Int J Biochem Cell Biol 1997;29:939-943.
36. Taipale J, Keski-Oja J: Growth factors in the extracellular matrix. FASEB J 1997;11:51-59.
37. Johnson RJ: Cytokines, growth factors and renal injury: Where do we go from here? Kidney Int 1997;52(suppl63):2-6.
38. Couchman JR, Woods A: Syndecans: Signaling and cell adhesion. J Cell Biochem 1996;61: 578-584.
39. Alvarez RJ, Sun MJ, Haverty TP, Iozzo RV, Mayers JC, Neilson EG: Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 1992;41:14-23.
40. Lewis M, Fine LG, Norman JT: Pexicrine effects of basement membrane components on paracrine signalling by renal tubular cells. Kidney Int 1996;49:48-58.
41. Rodemann HP; Müller G, Knecht A, Norman JT, Fine LG: Fibroblasts of the rabbit kidney in culture. I. Characterization of growth properties and identification of cell-specific markers. Am J Physiol 1991;261:F283-F291.
42. Müller GA, Frank J, Rodemann HP, Engler-Blum G: Human renal fibroblast cell lines (tFKIF and tNKF) are new tools to investigate pathophysiologic mechanisms of renal interstitial fibrosis. Exp Nephrol 1995;3:127-133.
43. Norman JT, Clark IM, Garcia PL: Hypoxia coordinately regulates extracellular matrix production and turnover to promote fibrogenesis in human renal fibroblasts: An oxygen-responsive system independent of autocrine mediators. Kidney Int, submitted 1999.
44. Johnson DW, Saunders HJ, Baxter RC, Field MJ, Pollock CA: Paracrine stimulation of human renal fibroblasts by proximal tubular cells. Kidney Int 1998;54:747-757.
45. Ivarsson M, McWhirter A, Black CM, Rubin C: Impaired regulation of collagen proαl(I) mRNA and change in pattern of collagen binding integrins on scleroderma fibroblasts. J Invest Dermatol 1993;101:216-221.
46. Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD: Myofibroblasts from scleroderma skin synthesise elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995; 270:3423-3428.
47. Magor G, Fraggetta F, Travail S, Lanzafame S: Immunohistochemical expression and distribution of alpha2beta1, alpha6beta1, alpha5beta1 integrins and their extracellular ligands type IV collagen, laminin and fibronectin in palmar fibromatosis. Gen Diag Pathol 1997;143:203-208.
48. Jin DK, Kim Y, Mauer M, Fioretto P, Vats A, Fish AJ: Relationships of cell proliferation and expression of integrin subunits and type I collagen in skin fibroblasts with renal lesions in patients with IDDM. Am J Kidney Dis 1998; 31:293-300.
49. Orphanides C, Norman JT: Hypoxia alters integrin expression in human proximal tubular epithelial cells (PTE) and cortical interstitial fibroblasts (CF). J Am Soc Nephrol 1997;8: 523.
50. Rodemann HP, Müller GA: Characterisation of human renal fibroblasts in health and disease. II. In vitro growth, differentiation and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 1991;17:684-686.
51. Norman JT, Goligorsky M: Ligation of integrins (I) dictates the phenotype of rat kidney fibroblasts (NRK-49F). J Am Soc Nephrol 1997;8:523.
52. Desmoulière A, Darby I, Costa AM, Raccurt M, Tuchweber B, Sommer P, Gabbiani G: Extracellular matrix deposition, lysyl oxidase expression and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest 1997;76:765-778.
53. Rønnov-Jessen L, Petersen OW: A function for filamentous α-smooth muscle actin: Retardation of motility in fibroblasts. J Cell Biol 1996; 134:76-80.
54. Kelynack K, Hewitson T, Pedagogos E, Nicholls K, Becker G: Renal myofibroblasts contract solidified collagen matrix. J Am Soc Nephrol 1997;8:519.
55. Kuhara T, Kagami S, Kuroda Y: Expression of β1 integrins on activated mesangial cells in human glomerulonephritis. J Am Soc Nephrol 1997;8:1679-1687.
56. Bissell DM: Hepatic fibrosis and wound repair: A progress report. J Gastroenterol 1998;33: 295-302.
57. Gotwals PJ, Chi-Rosso G, Lindner V, Yang J, Ling L, Fawell SE, Koteliansky VE: The alβ1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganisation. J Clin Invest 1996;97: 2469-2477.
58. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G: The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta 1. J Cell Biol 1998;142: 873-881.
59. Norman JT, Lewis MP, Fine LG, Orphanides C: The role of extracellular matrix (ECM) and growth factors in the activation of renal fibroblasts. J Am Soc Nephrol 1995;6:905.
60. Desmoulière A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
61. Brooks P: Role of integrins in angiogenesis. Eur J Cancer 1996;32:2423-2429.
62. Bunn HF, Poynton R: Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996;76:839-885.
63. Suzuma K, Takagi H, Otani A, Honda Y: Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine microvascular endothelial cells. J Invest Ophthalmol Vis Sci 1998;39:1028-1035.
64. Yao CC, Breuss J, Pytela R, Kramer RH: Functional expression of the α7 integrin receptor in differentiated smooth muscle cells. J Cell Sci 1997;110:1477-1487.
65. Schnapp LM, Breua JM, Ramos DM, Sheppard D, Pytela R: Sequence and tissue distribution of the human integrin alpha 8 subunit: A beta 1 associated alpha subunit expressed in smooth muscle cells. J Cell Sci 1995;108:537-544.
66. Desmoulière A, Badid C, Bochaton-Piallat ML, Gabbiani G: Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol 1997;29: 19-30.
67. Malik RK: Regulation of apoptosis by integrin receptors. J Pediatr Hematol Oncol 1997;19: 541-545.
68. Rozzo C, Chiesa V, Caridi G, Pagnan G, Ponzoni M: Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion. Int J Cancer 1997;70: 688-698.
69. Brooks PC, Montgomery AMP, Rosenfled M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin avβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157-1164.
70. Vassalli J-D, Sappino A-P, Belin D: The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
71. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, Engler JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
72. Stetler-Stevenson WG: Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148: 1345-1350.
73. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitors of metalloproteinases (TIMP. aka ERP): Structure, control of expression and biological functions. Pharmacol Ther 1993;59:329-341.
74. Gomez DE, Alonso DF, Yoshiji H, Thorgiesson UP: Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-122.
75. Riikonen T, Westermarck J, Koivisto L, Borberg A, Kähäri V-M, Heino J: Integrin α1β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J Biol Chem 1995;270:13548-13552.
76. Xue W, Mizumaki I, Rodd RF, Petty HR: Urokinase plasminogen activator receptors associate with beta 1 and beta3 integrins of fibrosarcoma cells: Dependence on extracellular matrix components. Cancer Res 1997;57:1682-1689.
77. Preissner KT, May AE, Wohn KD, Germer M, Kanse SM: Molecular cross talk between adhesion receptors and proteolytic cascades in vascular remodelling. Thromb Haemost 1997;78: 88-95.
78. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Ainmes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localisation of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996;85:683-693.
79. Mercier I, Lechaire JP, Desmoulière A, Gaill F, Aumailley M: Interactions of human skin fibroblasts with monomeric or fibrillar collagens induce different organisation of the cytoskeleton. Exp Cell Res 1996;225:245-266.
80. Sudbeck BD, Parks WC, Welgus HG, Pentland AP: Induction and repression of collagenase by keratinocytes is controlled by distinct components of different extracellular matrix components. J Biol Chem 1997;272:22103-22110.
81. Langholz O, Rockel D, Mauch C, Kozlowska E, Bank I, Kreig T: Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by α1β1 and α2β1 integrins. J Cell Biol 1995;131:1903-1915.
82. Xie B, Laouar A, Huberman E: Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation. J Biol Chem 1998;273:11576-11582.
83. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z: Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995;129:867-879.
84. Kjoller L, Kanse SM, Kirkergaard T, Rodenburg KW, Ronne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA: Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp Cell Res 1997;32: 420-429.
85. Schwarting A, Schlaak J, Lotz J, Pfers I Meyerzum Buschenfelde KH, Mayet WJ: Endothelin modulates the expression of adhesion molecules on fibroblast-like synovial cells. Scand J Rheumatol 1996;25:246-256.
86. Farrell DH, Al-Mondhiry HA: Human fibroblast adhesion to fibrinogen. Biochemistry 1997;6:1123-1128.
87. Svee K, White J, Vaillant P, Jessurun J, Roongta U, Krumwiede M, Johnson D, Henke C: Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. Am J Respir Crit Care Med 1996;154:1819-1828.
88. Ricardo SD, Levinson ME, De Joseph MR, Diamond JR: Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 1996;50:202-210.
89. Harning R, Pelletier J, Lubbe K, Takei F, Merluzzi VJ: Monoclonal antibody to MALA-2 (ICAM-1 reduces autoimmune nephritis in kd/kd mice. Clin Immunol Immunopathol 1992;64:129-134.
90. Vogel W, Gish GD, Alves F, Pawson T: The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1997;1:13-23.
91. Shrivastava A, Radziejewski C, Campbell E, Kovac L, McGlynn M, Ryan TE, Davies S, Goldfarb MP, Glass DJ, Lernke G, Yancopoulos GD: An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell 1997;1:25-34.
92. Roth T, Podesta F, Stepp MA, Boeri D, Lorenzi M: Integrin overexpression induced by high glucose and by human diabetes: Potential pathway to cell dysfunction in diabetic microangiopathy. Proc Natl Acad Sci USA 1993;90: 9640-9644.
93. Krishnamurti U, Rondeau E, Sraer JD, Michael AF, Tsilibary EC: Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J Biol Chem 1997;272:27966-27970.
94. Norman J, Brought C, Romanov V, Goligorsky M: Glycation of the extracellular matrix (ECM) alters rat renal fibroblast (NRK-49F) growth, differentiation and ECM production. J Am Soc Nephrol 1998;9:638A.